Annual CFF
$454.09 M
+$480.53 M+1817.51%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual cash flow from financing activities is currently $454.09 million, with the most recent change of +$480.53 million (+1817.51%) on 31 December 2023. During the last 3 years, it has risen by +$456.34 million (+20317.85%). AMPH annual CFF is now at all-time high.AMPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$22.82 M
-$12.10 M-112.92%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly cash flow from financing activities is currently -$22.82 million, with the most recent change of -$12.10 million (-112.92%) on 30 September 2024. Over the past year, it has dropped by -$109.43 million (-126.34%). AMPH quarterly CFF is now -105.33% below its all-time high of $428.11 million, reached on 30 June 2023.AMPH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$94.19 M
-$109.43 M-718.27%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM cash flow from financing activities is currently -$94.19 million, with the most recent change of -$109.43 million (-718.27%) on 30 September 2024. Over the past year, it has dropped by -$579.21 million (-119.42%). AMPH TTM CFF is now -119.42% below its all-time high of $485.01 million, reached on 30 September 2023.AMPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1817.5% | -126.3% | -119.4% |
| 3 y3 years | +10000.0% | -38.4% | -229.9% |
| 5 y5 years | +1715.8% | -486.8% | -500.5% |
AMPH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1326.7% | -105.3% | +51.5% | -119.4% | at low |
| 5 y | 5 years | at high | +1326.7% | -105.3% | +51.5% | -119.4% | at low |
| alltime | all time | at high | +1326.7% | -105.3% | +51.5% | -119.4% | at low |
Amphastar Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$22.82 M(+112.9%) | -$94.19 M(-718.3%) |
| June 2024 | - | -$10.72 M(-21.1%) | $15.23 M(-96.6%) |
| Mar 2024 | - | -$13.58 M(-71.2%) | $454.06 M(-0.0%) |
| Dec 2023 | $454.09 M(-1817.5%) | -$47.08 M(-154.4%) | $454.09 M(-6.4%) |
| Sept 2023 | - | $86.61 M(-79.8%) | $485.01 M(+26.2%) |
| June 2023 | - | $428.11 M(-3260.0%) | $384.47 M(-961.4%) |
| Mar 2023 | - | -$13.55 M(-16.2%) | -$44.63 M(+68.8%) |
| Dec 2022 | -$26.44 M(-28.6%) | -$16.16 M(+16.0%) | -$26.44 M(+39.4%) |
| Sept 2022 | - | -$13.93 M(+1301.5%) | -$18.97 M(-11.9%) |
| June 2022 | - | -$994.00 K(-121.4%) | -$21.53 M(-16.3%) |
| Mar 2022 | - | $4.65 M(-153.4%) | -$25.73 M(-30.5%) |
| Dec 2021 | -$37.02 M(+1548.2%) | -$8.70 M(-47.3%) | -$37.02 M(+29.7%) |
| Sept 2021 | - | -$16.49 M(+217.7%) | -$28.55 M(+89.3%) |
| June 2021 | - | -$5.19 M(-21.8%) | -$15.08 M(-688.3%) |
| Mar 2021 | - | -$6.64 M(+2824.7%) | $2.56 M(-214.2%) |
| Dec 2020 | -$2.25 M(-40.6%) | -$227.00 K(-92.5%) | -$2.25 M(-81.9%) |
| Sept 2020 | - | -$3.03 M(-124.3%) | -$12.40 M(-6.5%) |
| June 2020 | - | $12.46 M(-208.8%) | -$13.26 M(-49.9%) |
| Mar 2020 | - | -$11.45 M(+10.3%) | -$26.46 M(+599.5%) |
| Dec 2019 | -$3.78 M(-115.1%) | -$10.38 M(+167.0%) | -$3.78 M(-116.1%) |
| Sept 2019 | - | -$3.89 M(+424.0%) | $23.52 M(-48.0%) |
| June 2019 | - | -$742.00 K(-106.6%) | $45.21 M(-3.9%) |
| Mar 2019 | - | $11.23 M(-33.6%) | $47.06 M(+88.2%) |
| Dec 2018 | $25.01 M | $16.92 M(-5.0%) | $25.01 M(+243.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $17.80 M(+1504.0%) | $7.28 M(-145.4%) |
| June 2018 | - | $1.11 M(-110.3%) | -$16.03 M(+134.8%) |
| Mar 2018 | - | -$10.83 M(+1250.1%) | -$6.83 M(-11.5%) |
| Dec 2017 | -$7.72 M(-208.1%) | -$802.00 K(-85.5%) | -$7.72 M(-5.6%) |
| Sept 2017 | - | -$5.51 M(-153.4%) | -$8.18 M(-175.7%) |
| June 2017 | - | $10.31 M(-188.0%) | $10.81 M(+340.2%) |
| Mar 2017 | - | -$11.72 M(+829.3%) | $2.46 M(-65.6%) |
| Dec 2016 | $7.14 M(+219.2%) | -$1.26 M(-109.4%) | $7.14 M(+152.3%) |
| Sept 2016 | - | $13.47 M(+586.6%) | $2.83 M(-119.7%) |
| June 2016 | - | $1.96 M(-127.9%) | -$14.36 M(+55.4%) |
| Mar 2016 | - | -$7.03 M(+26.2%) | -$9.24 M(-513.1%) |
| Dec 2015 | $2.24 M(-93.0%) | -$5.57 M(+49.7%) | $2.24 M(-400.3%) |
| Sept 2015 | - | -$3.72 M(-152.5%) | -$745.00 K(-149.5%) |
| June 2015 | - | $7.08 M(+59.4%) | $1.50 M(-94.5%) |
| Mar 2015 | - | $4.45 M(-152.0%) | $27.38 M(-14.7%) |
| Dec 2014 | $32.12 M(-442.8%) | -$8.55 M(+481.0%) | $32.12 M(-13.1%) |
| Sept 2014 | - | -$1.47 M(-104.5%) | $36.97 M(-4.7%) |
| June 2014 | - | $32.96 M(+259.1%) | $38.80 M(-498.7%) |
| Mar 2014 | - | $9.18 M(-348.1%) | -$9.73 M(+3.9%) |
| Dec 2013 | -$9.37 M(-140.3%) | -$3.70 M(-1130.6%) | -$9.37 M(+65.3%) |
| Sept 2013 | - | $359.00 K(-102.3%) | -$5.67 M(-6.0%) |
| June 2013 | - | -$15.57 M(-263.2%) | -$6.03 M(-163.2%) |
| Mar 2013 | - | $9.54 M | $9.54 M |
| Dec 2012 | $23.24 M(-371.0%) | - | - |
| Dec 2011 | -$8.58 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual CFF year-on-year change?
- What is Amphastar Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly CFF year-on-year change?
- What is Amphastar Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM CFF year-on-year change?
What is Amphastar Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AMPH is $454.09 M
What is the all time high annual CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual cash flow from financing activities is $454.09 M
What is Amphastar Pharmaceuticals annual CFF year-on-year change?
Over the past year, AMPH annual cash flow from financing activities has changed by +$480.53 M (+1817.51%)
What is Amphastar Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AMPH is -$22.82 M
What is the all time high quarterly CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly cash flow from financing activities is $428.11 M
What is Amphastar Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AMPH quarterly cash flow from financing activities has changed by -$109.43 M (-126.34%)
What is Amphastar Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AMPH is -$94.19 M
What is the all time high TTM CFF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM cash flow from financing activities is $485.01 M
What is Amphastar Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AMPH TTM cash flow from financing activities has changed by -$579.21 M (-119.42%)